ORIGINAL ARTICLE: Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia - Concepedia

Concepedia

Publication | Open Access

ORIGINAL ARTICLE: Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia

DOI Full Paper Access

57

Citations

21

References

2010

Year

Tricia Tan, Inês Zimbarra Cabrita, Davina J. Hensman Moss, Joanna Grogono, Waljit S. Dhillo, Kevin Baynes, Joseph Eliahoo, Karim Meeran, Stephen T. Robinson, Petros Nihoyannopoulos,

Clinical Endocrinology

Abstract

Our data demonstrates that there is no association between cabergoline treatment for hyperprolactinaemia and valvulopathy. This study therefore supports continued use of low-dose cabergoline for patients with hyperprolactinaemia.

References

	Year	Citations

Page 1